Indeed, one pharmacy (unrelated to BPC specifically) was hit with FDA warnings for sterility problems in its peptide injectable products
However, Eli Lilly also makes a medication called Zepbound (tirzepatide), which contains the same exact active ingredient as Mounjaro but is FDA-approved for weight loss instead
Acknowledgements We thank our colleagues for many helpful discussions, and in particular T
Another study compared PRP to just dextrose prolotherapy it was a very small study that showed that PRP improved the function in that patient more so than prolotherapy, though prolotherapy did help him out with the pain
Structurally, its essentially a modified version of GHRH with a small molecular addition that increases its stability, allowing it to be used therapeutically
Conclusion: A Dual Path With Encouraging Direction GHK-Cu's unique dual-track regulatory path topical from Category 1 and injectable from Category 2, both heading to PCAC review before February 2027 reflects the complexity and nuance of the FDA's current approach to peptide regulation
